Company Search:
Advanced Search
Sponsored Links
BEACON Pharmaceutical Ltd Company Snapshot
BEACON Pharmaceutical Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares BEACON Pharmaceutical Ltd with three other pharmaceutical manufacturers in Asia: Bora Pharmaceuticals Co Ltd of TAIWAN (2020 sales of 1.80 billion Taiwanese Dollars [US$64.80 million] of which 73% was Manufacture Department), Jiangxi Synergy Pharmaceutical Co Ltd of CHINA (435.42 million Chinese Renmimbi [US$67.38 million] of which 100% was Pharmaceutical manufacture), and Daebong LS Company Limited which is based in KOREA (SOUTH) (76.25 billion Korean Won [US$64.51 million] of which 80% was Manufacturing).

Sales Analysis. Sales were up sharply during the third fiscal quarter of 2021 versus the previous year's third quarter. During the third fiscal quarter of 2021, sales at BEACON Pharmaceutical Ltd totalled 2.60 billion Bangladeshi Taka. This is an increase of 89.2% from the 1.37 billion Bangladeshi Taka in sales at the company during the third quarter of 2020. This was the biggest same quarter rise in sales at BEACON Pharmaceutical Ltd in the previous 26 quarters. During the first three quarters of 2021, sales totalled 6.33 billion Bangladeshi Taka, which is 50.6% higher than through the first three fiscal quarters of 2020. During the previous 15 quarters, sales at BEACON Pharmaceutical Ltd have increased compared with the same quarter in the previous year. BEACON Pharmaceutical Ltd reported sales of 5.59 billion Bangladeshi Taka (US$65.52 million) for the fiscal year ending June of 2020. This represents an increase of 20.3% versus 2019, when the company's sales were 4.65 billion Bangladeshi Taka. Sales at BEACON Pharmaceutical Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 172%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BEACON Pharmaceutical Ltd
  Stock Performance Chart for BEACON Pharmaceutical Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/16/2021): 217.30
(Figures in Bangladeshi Taka)
1 Week -2.7%   13 Weeks 6.9%  
4 Weeks 86.5%   52 Weeks 191.3%  
BEACON Pharmaceutical Ltd Key Data:
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 5,590,790,317
(Year Ending Jan 2021).
Employees: N/A
  Currency: Bangladeshi Taka Market Cap: 50,196,300,000
  Fiscal Yr Ends: June Shares Outstanding: 231,000,000
  Share Type: Ordinary Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.